Ocean Biomedical, Inc.

Aesther Healthcare Acquisition Corp, trading on Nasdaq under the ticker AEHA, is a blank-check company formed to pursue a business combination in the healthcare and life sciences sector, having completed its IPO in 2021 under the sponsorship of Aesther Healthcare Management LLC. The July 2022 8-K filing relates to its proposed de-SPAC transaction with Ocean Biomedical, Inc., a Providence, Rhode Island-based biopharmaceutical company co-founded at Brown University and focused on developing treatments in oncology, pulmonary fibrosis, and infectious disease. The combination marks AEHA's progression through the standard SPAC lifecycle from search to announced merger target. Sign up at SpacDesk for full filing history, timeline analytics, and real-time deal status on AEHA and every active SPAC in the market.